Edison Investment Research Limited: Laboratorios Farmacéuticos ROVI (ROVI): All Good Things Come in Threes | LONDON, UK / ACCESSWIRE / December 11, 2020 / Laboratorios Farmacéuticos ROVI's (ROVI's) recent capital markets day (CMD) highlighted the strong positioning of its three key franchises. Combined unit... ► Artikel lesen |
Laboratorios Farmaceuticos ROVI - Momentum continues across key franchises | Reported 9M20 numbers highlight continual strength in sales across key franchises and ongoing margin expansion. ROVI reported operating revenue of €302.1m (+12%). Within the low molecular weight heparin... ► Artikel lesen |